UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000781
Receipt number R000000936
Scientific Title Randomized phase II trial of adjuvant chemotherapy (CBDCA+GEM vs TS1+DTX) for completely resected non-small cell lung cancer
Date of disclosure of the study information 2007/08/01
Last modified on 2014/07/30 13:06:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized phase II trial of adjuvant chemotherapy (CBDCA+GEM vs TS1+DTX) for completely resected non-small cell lung cancer

Acronym

CBDCA+GEM vs TS1+DTX phase II trial for completely resected lung cancer

Scientific Title

Randomized phase II trial of adjuvant chemotherapy (CBDCA+GEM vs TS1+DTX) for completely resected non-small cell lung cancer

Scientific Title:Acronym

CBDCA+GEM vs TS1+DTX phase II trial for completely resected lung cancer

Region

Japan


Condition

Condition

non-small cell lung cancer

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the relapse free survival of completely resected non-small cell lung cancer with adjuvant chemotherapy (CBDCA+GEM vs TS1+DTX)

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

2-year relapse free survival

Key secondary outcomes

toxicity


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

adjuvant chemotherapy with CBDCA+GEM

Interventions/Control_2

adjuvant chemotherapy with TS1+DTX

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

76 years-old >

Gender

Male and Female

Key inclusion criteria

non-small cell lung cancer
lobectomy or more with ND2 lymphnode dissection
complete resection
pathological stage IB, II, IIIA
ECOG performance status 0, 1

Key exclusion criteria

symptomatic interstitial pneumonia
multiple lung cancer or other-type cancer within 5 years
severe organ failure
past history of radiotherapy or chemotherapy
pregnant or expecting mother

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takao Tsushima

Organization

Hirosaki University Hospital

Division name

Department of Thoracic Surgery

Zip code


Address

53Honcho, Hirosaki, Aomori

TEL

0172-39-5074

Email

tsusim@cc.hirosaki-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Chiaki Endo

Organization

Japanese Northern East Area Thoracic Surgery Study Group

Division name

Central study center

Zip code


Address

4-1Seiryo-machi, Aoba-ku, Sendai

TEL

022-717-8526

Homepage URL


Email

endo@idac.tohoku.ac.jp


Sponsor or person

Institute

Japanese Northern East Area Thoracic Surgery Study Group

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

弘前大学病院(青森県)、青森県立中央病院(青森県)、岩手県立胆沢病院(岩手県)、東北大学病院(宮城県)、宮城がんセンター(宮城県)、山形大学病院(山形県)、福島医大病院(福島県)、太田西の内病院(福島県)、総合南東北病院(福島県)、金沢医大病院(石川県)、芳珠記念病院(石川県)、獨協医大病院(栃木県)


Other administrative information

Date of disclosure of the study information

2007 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2007 Year 06 Month 22 Day

Date of IRB


Anticipated trial start date

2007 Year 08 Month 01 Day

Last follow-up date

2011 Year 08 Month 01 Day

Date of closure to data entry

2012 Year 11 Month 01 Day

Date trial data considered complete

2014 Year 11 Month 01 Day

Date analysis concluded

2014 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 07 Month 30 Day

Last modified on

2014 Year 07 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000936


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name